Direct immunofluorescence in lupus erythematosus (LE)

Area of Science:

• Dermatology
• Immunology
• Pathology

Background:

• Lupus erythematosus (LE) encompasses various autoimmune conditions affecting the skin.
• Cutaneous lupus erythematosus (CLE) subtypes include discoid lupus erythematosus (DLE), subacute cutaneous lupus erythematosus (SALE), and systemic lupus erythematosus (SLE).
• Direct immunofluorescence (DIF) is a diagnostic tool for identifying immune deposits in skin biopsies.

Purpose of the Study:

• To evaluate the utility of DIF in diagnosing cutaneous lupus erythematosus.
• To determine the prevalence of specific immunoglobulins and complement deposition in skin lesions of different LE subtypes.

Main Methods:

• A cohort of 126 patients with LE was studied, categorized into DLE (84), SALE (13), and SLE (29).
• Skin biopsies were obtained from lesional skin.
• Direct immunofluorescence (DIF) was performed on all biopsies.

Main Results:

• Positive DIF results were observed in 69% of DLE, 61.5% of SALE, and 72.4% of SLE cases.
• Immunoglobulin M (IgM) was the most frequently detected immunoglobulin.
• The combined finding of IgM and C3 was the next most common immune deposit.

Conclusions:

• DIF is a valuable diagnostic method for cutaneous lupus erythematosus.
• IgM and IgM + C3 deposits are characteristic findings in LE skin lesions.
• The prevalence of positive DIF results is consistent across DLE, SALE, and SLE subtypes.